Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,808 | 282 | 96.3% |
| Debt forgiveness | $207.67 | 1 | 3.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16.44 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,174 | 54 | $0 (2024) |
| ABBVIE INC. | $1,012 | 39 | $0 (2024) |
| Novo Nordisk Inc | $556.93 | 36 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $411.58 | 10 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $268.22 | 9 | $0 (2024) |
| Corium, LLC | $233.94 | 8 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $220.41 | 14 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $217.95 | 13 | $0 (2024) |
| GlaxoSmithKline, LLC. | $214.69 | 8 | $0 (2024) |
| Baxter Healthcare | $207.67 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $560.23 | 24 | ABBVIE INC. ($256.34) |
| 2023 | $1,867 | 85 | AbbVie Inc. ($302.51) |
| 2022 | $1,255 | 71 | ABBVIE INC. ($239.79) |
| 2021 | $982.94 | 47 | Biohaven Pharmaceuticals, Inc. ($411.58) |
| 2020 | $345.59 | 19 | PFIZER INC. ($219.76) |
| 2019 | $488.21 | 20 | PFIZER INC. ($327.86) |
| 2018 | $412.06 | 16 | PFIZER INC. ($216.27) |
| 2017 | $120.77 | 2 | AbbVie, Inc. ($98.51) |
All Payment Transactions
284 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Respiratory | ||||||
| 06/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Gastroenterology | ||||||
| 05/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.28 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Oncology | ||||||
| 04/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Diabetes | ||||||
| 04/05/2024 | ALK-Abello, Inc | Odactra (Drug), Grastek, Ragwitek | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Allergy and Immunology | ||||||
| 04/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Bone Health | ||||||
| 03/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: PAIN | ||||||
| 03/05/2024 | ALK-Abello, Inc | Odactra (Drug), Ragwitek | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Allergy and Immunology | ||||||
| 02/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Gastroenterology | ||||||
| 02/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: NEUROSCIENCE | ||||||
| 02/26/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: VACCINES | ||||||
| 02/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: RESPIRATORY | ||||||
| 02/19/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $15.63 | General |
| 02/16/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 02/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PENBRAYA | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: VACCINES | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Respiratory | ||||||
| 01/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Bone Health | ||||||
| 01/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 270 | 516 | $70,489 | $36,039 |
| 2022 | 7 | 229 | 454 | $61,495 | $31,747 |
| 2021 | 9 | 261 | 501 | $65,223 | $37,284 |
| 2020 | 6 | 172 | 316 | $43,750 | $19,987 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 321 | $56,175 | $27,246 | 48.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 29 | 29 | $5,220 | $3,762 | 72.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 31 | 31 | $3,875 | $2,488 | 64.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 16 | 16 | $1,280 | $1,151 | 89.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $640.00 | $500.00 | 78.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 25 | 25 | $875.00 | $459.75 | 52.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 29 | 31 | $1,860 | $328.44 | 17.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 41 | 47 | $564.00 | $103.40 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 298 | $52,150 | $26,229 | 50.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 26 | 26 | $4,680 | $3,452 | 73.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 13 | 13 | $1,040 | $891.02 | 85.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $560.00 | $418.18 | 74.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 19 | 19 | $665.00 | $353.59 | 53.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 28 | 29 | $1,740 | $282.12 | 16.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 39 | 55 | $660.00 | $121.99 | 18.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 305 | $53,375 | $29,817 | 55.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 23 | 23 | $4,140 | $3,134 | 75.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 14 | $1,680 | $1,323 | 78.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 20 | 20 | $1,615 | $1,301 | 80.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 25 | 25 | $875.00 | $475.50 | 54.3% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 11 | 11 | $550.00 | $445.28 | 81.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 20 | 20 | $600.00 | $345.39 | 57.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 28 | 29 | $1,740 | $320.58 | 18.4% |
| 81003 | Automated urinalysis test | Office | 2021 | 43 | 54 | $648.00 | $121.50 | 18.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 77 | 214 | $37,450 | $16,737 | 44.7% |
About Jamie Baines
Jamie Baines is a Sports Medicine healthcare provider based in Farmington Hills, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2008. The National Provider Identifier (NPI) number assigned to this provider is 1851553762.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jamie Baines has received a total of $6,032 in payments from pharmaceutical and medical device companies, with $560.23 received in 2024. These payments were reported across 284 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($5,808).
As a Medicare-enrolled provider, Baines has provided services to 932 Medicare beneficiaries, totaling 1,787 services with total Medicare billing of $125,057. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Other Specialties Family Medicine
- Location Farmington Hills, MI
- Active Since 07/01/2008
- Last Updated 06/04/2024
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1851553762
Products in Payments
- NURTEC ODT (Drug) $715.77
- EUCRISA (Drug) $449.10
- VRAYLAR (Drug) $440.77
- CHANTIX (Drug) $347.74
- UBRELVY (Drug) $342.77
- Wegovy (Drug) $268.83
- Azstarys (Drug) $233.94
- XIFAXAN (Drug) $217.95
- EVENITY (Biological) $149.49
- QULIPTA (Drug) $144.82
- BEVESPI AEROSPHERE (Drug) $130.62
- SHINGRIX (Biological) $120.84
- UNITHROID (Drug) $101.04
- Androgel (Drug) $98.51
- BEXSERO (Biological) $93.85
- Kerendia (Drug) $90.80
- Xofluza (Drug) $86.26
- MOUNJARO (Drug) $82.27
- Saxenda (Drug) $79.44
- STIOLTO RESPIMAT (Drug) $74.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.